Video

Roswell Park Set to Open Several New Trials this Year for Innovative CAR T-Cell Therapies

CAR T-cell therapies are the future of cancer treatment and Roswell Park Comprehensive Cancer Center is preparing to open a number of new trials based on research originating here and in partnership with the industry.

Video

Roswell Park Accelerates CAR T-Cell Innovation with Upcoming Trials

Renier Brentjens, MD, PhD, has spent most of his career pioneering research into the development and use of CAR T-cell therapies in the hopes of finding innovative and effective treatments for cancer.

Video

New CAR T Clinical Trials Underway at Roswell Park for Solid Tumor, Non-cancerous Diseases

While the focus and promise of CAR T-cell therapies has long been on liquid tumors and hematologic malignancies, new trials under way at Roswell Park Comprehensive Cancer Center are expanding the applications of immunotherapy to include other diseases.

News

Investigators Hope for Potential Breakthrough in Dual Cellular Therapy Approach for Advanced and Metastatic Solid Tumors

Roswell Park Comprehensive Cancer Center is moving the science forward by offering clinical trials aimed at extending the benefits of those therapies to patients with all types of solid tumors.

News

Governor Hochul Celebrates Opening of New York’s First Cell and Gene Therapy Hub at Roswell Park Comprehensive Cancer Center In Buffalo

Governor Kathy Hochul today celebrated the opening of the Roswell Park GMP Engineering and Cell Manufacturing Facility, New York's first cell and gene therapy hub, located at Roswell Park Comprehensive Cancer Center in Buffalo.

Video

Graft Versus Host Disease No Longer Poses High Risk to Transplant Patients

Graft versus host disease (GVHD) used to present such a risk to transplant patients, an estimate 10-15% of patients would develop a fatal case of it.